img

Global Bisphosphonate Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bisphosphonate Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Bisphosphonates are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.
Bisphosphonate Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bisphosphonate Drug market is projected to reach US$ 1241.1 million in 2029, increasing from US$ 854 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Postmenopausal Osteoporosis and Men with Osteoporosis are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bisphosphonate Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis
Segment by Type
Alendronate
Risedronate
Zoledronic Acid
Other Bisphosphonate Drug

Segment by Application


Postmenopausal Osteoporosis
Men with Osteoporosis
Paget’s Disease
Bone Loss Caused by Cancer Treatment
Osteoporosis Imperfecta in Children

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bisphosphonate Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bisphosphonate Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bisphosphonate Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Bisphosphonate Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bisphosphonate Drug introduction, etc. Bisphosphonate Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Bisphosphonate Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Bisphosphonate Drug Market Overview
1.1 Bisphosphonate Drug Product Overview
1.2 Bisphosphonate Drug Market Segment by Type
1.2.1 Alendronate
1.2.2 Risedronate
1.2.3 Zoledronic Acid
1.2.4 Other Bisphosphonate Drug
1.3 Global Bisphosphonate Drug Market Size by Type
1.3.1 Global Bisphosphonate Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Bisphosphonate Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Bisphosphonate Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bisphosphonate Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Bisphosphonate Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Bisphosphonate Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Bisphosphonate Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Bisphosphonate Drug Sales Breakdown by Type (2018-2024)
2 Global Bisphosphonate Drug Market Competition by Company
2.1 Global Top Players by Bisphosphonate Drug Sales (2018-2024)
2.2 Global Top Players by Bisphosphonate Drug Revenue (2018-2024)
2.3 Global Top Players by Bisphosphonate Drug Price (2018-2024)
2.4 Global Top Manufacturers Bisphosphonate Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bisphosphonate Drug Market Competitive Situation and Trends
2.5.1 Bisphosphonate Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Bisphosphonate Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bisphosphonate Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Bisphosphonate Drug Market
2.8 Key Manufacturers Bisphosphonate Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bisphosphonate Drug Status and Outlook by Region
3.1 Global Bisphosphonate Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bisphosphonate Drug Historic Market Size by Region
3.2.1 Global Bisphosphonate Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Bisphosphonate Drug Sales in Value by Region (2018-2024)
3.2.3 Global Bisphosphonate Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Bisphosphonate Drug Forecasted Market Size by Region
3.3.1 Global Bisphosphonate Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Bisphosphonate Drug Sales in Value by Region (2024-2029)
3.3.3 Global Bisphosphonate Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bisphosphonate Drug by Application
4.1 Bisphosphonate Drug Market Segment by Application
4.1.1 Postmenopausal Osteoporosis
4.1.2 Men with Osteoporosis
4.1.3 Paget’s Disease
4.1.4 Bone Loss Caused by Cancer Treatment
4.1.5 Osteoporosis Imperfecta in Children
4.2 Global Bisphosphonate Drug Market Size by Application
4.2.1 Global Bisphosphonate Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Bisphosphonate Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Bisphosphonate Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bisphosphonate Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Bisphosphonate Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Bisphosphonate Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Bisphosphonate Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Bisphosphonate Drug Sales Breakdown by Application (2018-2024)
5 North America Bisphosphonate Drug by Country
5.1 North America Bisphosphonate Drug Historic Market Size by Country
5.1.1 North America Bisphosphonate Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bisphosphonate Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Bisphosphonate Drug Sales in Value by Country (2018-2024)
5.2 North America Bisphosphonate Drug Forecasted Market Size by Country
5.2.1 North America Bisphosphonate Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Bisphosphonate Drug Sales in Value by Country (2024-2029)
6 Europe Bisphosphonate Drug by Country
6.1 Europe Bisphosphonate Drug Historic Market Size by Country
6.1.1 Europe Bisphosphonate Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bisphosphonate Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Bisphosphonate Drug Sales in Value by Country (2018-2024)
6.2 Europe Bisphosphonate Drug Forecasted Market Size by Country
6.2.1 Europe Bisphosphonate Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Bisphosphonate Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Bisphosphonate Drug by Region
7.1 Asia-Pacific Bisphosphonate Drug Historic Market Size by Region
7.1.1 Asia-Pacific Bisphosphonate Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bisphosphonate Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Bisphosphonate Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Bisphosphonate Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Bisphosphonate Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bisphosphonate Drug Sales in Value by Region (2024-2029)
8 Latin America Bisphosphonate Drug by Country
8.1 Latin America Bisphosphonate Drug Historic Market Size by Country
8.1.1 Latin America Bisphosphonate Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bisphosphonate Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Bisphosphonate Drug Sales in Value by Country (2018-2024)
8.2 Latin America Bisphosphonate Drug Forecasted Market Size by Country
8.2.1 Latin America Bisphosphonate Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bisphosphonate Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Bisphosphonate Drug by Country
9.1 Middle East and Africa Bisphosphonate Drug Historic Market Size by Country
9.1.1 Middle East and Africa Bisphosphonate Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bisphosphonate Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Bisphosphonate Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Bisphosphonate Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Bisphosphonate Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bisphosphonate Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Bisphosphonate Drug Products Offered
10.1.5 Merck Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Teva Bisphosphonate Drug Products Offered
10.2.5 Teva Recent Development
10.3 Mylan
10.3.1 Mylan Company Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Mylan Bisphosphonate Drug Products Offered
10.3.5 Mylan Recent Development
10.4 Apotex Corp
10.4.1 Apotex Corp Company Information
10.4.2 Apotex Corp Introduction and Business Overview
10.4.3 Apotex Corp Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Apotex Corp Bisphosphonate Drug Products Offered
10.4.5 Apotex Corp Recent Development
10.5 Cobalt Pharmaceuticals
10.5.1 Cobalt Pharmaceuticals Company Information
10.5.2 Cobalt Pharmaceuticals Introduction and Business Overview
10.5.3 Cobalt Pharmaceuticals Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Cobalt Pharmaceuticals Bisphosphonate Drug Products Offered
10.5.5 Cobalt Pharmaceuticals Recent Development
10.6 Genentech
10.6.1 Genentech Company Information
10.6.2 Genentech Introduction and Business Overview
10.6.3 Genentech Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Genentech Bisphosphonate Drug Products Offered
10.6.5 Genentech Recent Development
10.7 Novartis Pharmaceuticals
10.7.1 Novartis Pharmaceuticals Company Information
10.7.2 Novartis Pharmaceuticals Introduction and Business Overview
10.7.3 Novartis Pharmaceuticals Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Novartis Pharmaceuticals Bisphosphonate Drug Products Offered
10.7.5 Novartis Pharmaceuticals Recent Development
10.8 Sanofi-Aventis
10.8.1 Sanofi-Aventis Company Information
10.8.2 Sanofi-Aventis Introduction and Business Overview
10.8.3 Sanofi-Aventis Bisphosphonate Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sanofi-Aventis Bisphosphonate Drug Products Offered
10.8.5 Sanofi-Aventis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bisphosphonate Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bisphosphonate Drug Industrial Chain Analysis
11.4 Bisphosphonate Drug Market Dynamics
11.4.1 Bisphosphonate Drug Industry Trends
11.4.2 Bisphosphonate Drug Market Drivers
11.4.3 Bisphosphonate Drug Market Challenges
11.4.4 Bisphosphonate Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bisphosphonate Drug Distributors
12.3 Bisphosphonate Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Alendronate
Table 2. Major Company of Risedronate
Table 3. Major Company of Zoledronic Acid
Table 4. Major Company of Other Bisphosphonate Drug
Table 5. Global Bisphosphonate Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Bisphosphonate Drug Sales by Type (2018-2024) & (K Units)
Table 7. Global Bisphosphonate Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Bisphosphonate Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Bisphosphonate Drug Market Share in Value by Type (2018-2024)
Table 10. Global Bisphosphonate Drug Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Bisphosphonate Drug Sales by Type (2024-2029) & (K Units)
Table 12. Global Bisphosphonate Drug Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Bisphosphonate Drug Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Bisphosphonate Drug Sales Market Share in Value by Type (2024-2029)
Table 15. Global Bisphosphonate Drug Price by Type (2024-2029) & (USD/Unit)
Table 16. North America Bisphosphonate Drug Sales by Type (2018-2024) & (K Units)
Table 17. North America Bisphosphonate Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Bisphosphonate Drug Sales (K Units) by Type (2018-2024)
Table 19. Europe Bisphosphonate Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Bisphosphonate Drug Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Bisphosphonate Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Bisphosphonate Drug Sales (K Units) by Type (2018-2024)
Table 23. Latin America Bisphosphonate Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Bisphosphonate Drug Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Bisphosphonate Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Bisphosphonate Drug Sales by Company (2018-2024) & (K Units)
Table 27. Global Bisphosphonate Drug Sales Share by Company (2018-2024)
Table 28. Global Bisphosphonate Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Bisphosphonate Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Bisphosphonate Drug Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Bisphosphonate Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Bisphosphonate Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bisphosphonate Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Bisphosphonate Drug Market
Table 35. Key Manufacturers Bisphosphonate Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Bisphosphonate Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Bisphosphonate Drug Sales by Region (2018-2024) & (K Units)
Table 39. Global Bisphosphonate Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Bisphosphonate Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Bisphosphonate Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Bisphosphonate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Bisphosphonate Drug Sales by Region (2024-2029) & (K Units)
Table 44. Global Bisphosphonate Drug Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Bisphosphonate Drug Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Bisphosphonate Drug Sales Market Share in Value by Region (2024-2029)
Table 47. Global Bisphosphonate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 48. Global Bisphosphonate Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Bisphosphonate Drug Sales by Application (2018-2024) & (K Units)
Table 50. Global Bisphosphonate Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Bisphosphonate Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Bisphosphonate Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Bisphosphonate Drug Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Bisphosphonate Drug Sales by Application (2024-2029) & (K Units)
Table 55. Global Bisphosphonate Drug Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Bisphosphonate Drug Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Bisphosphonate Drug Sales Market Share in Value by Application (2024-2029)
Table 58. Global Bisphosphonate Drug Price by Application (2024-2029) & (USD/Unit)
Table 59. North America Bisphosphonate Drug Sales by Application (2018-2024) (K Units)
Table 60. North America Bisphosphonate Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Bisphosphonate Drug Sales by Application (2018-2024) (K Units)
Table 62. Europe Bisphosphonate Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Bisphosphonate Drug Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Bisphosphonate Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Bisphosphonate Drug Sales by Application (2018-2024) (K Units)
Table 66. Latin America Bisphosphonate Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Bisphosphonate Drug Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Bisphosphonate Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Bisphosphonate Drug Sales by Country (2018-2024) & (K Units)
Table 70. North America Bisphosphonate Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Bisphosphonate Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Bisphosphonate Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Bisphosphonate Drug Sales by Country (2024-2029) & (K Units)
Table 74. North America Bisphosphonate Drug Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Bisphosphonate Drug Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Bisphosphonate Drug Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Bisphosphonate Drug Sales by Country (2018-2024) & (K Units)
Table 78. Europe Bisphosphonate Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Bisphosphonate Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Bisphosphonate Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Bisphosphonate Drug Sales by Country (2024-2029) & (K Units)
Table 82. Europe Bisphosphonate Drug Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Bisphosphonate Drug Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Bisphosphonate Drug Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Bisphosphonate Drug Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Bisphosphonate Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Bisphosphonate Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Bisphosphonate Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Bisphosphonate Drug Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Bisphosphonate Drug Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Bisphosphonate Drug Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Bisphosphonate Drug Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Bisphosphonate Drug Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Bisphosphonate Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Bisphosphonate Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Bisphosphonate Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Bisphosphonate Drug Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Bisphosphonate Drug Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Bisphosphonate Drug Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Bisphosphonate Drug Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Bisphosphonate Drug Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Bisphosphonate Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Bisphosphonate Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Bisphosphonate Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Bisphosphonate Drug Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Bisphosphonate Drug Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Bisphosphonate Drug Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Bisphosphonate Drug Sales Market Share in Value by Country (2024-2029)
Table 109. Merck Company Information
Table 110. Merck Introduction and Business Overview
Table 111. Merck Bisphosphonate Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Merck Bisphosphonate Drug Product
Table 113. Merck Recent Development
Table 114. Teva Company Information
Table 115. Teva Introduction and Business Overview
Table 116. Teva Bisphosphonate Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Teva Bisphosphonate Drug Product
Table 118. Teva Recent Development
Table 119. Mylan Company Information
Table 120. Mylan Introduction and Business Overview
Table 121. Mylan Bisphosphonate Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Mylan Bisphosphonate Drug Product
Table 123. Mylan Recent Development
Table 124. Apotex Corp Company Information
Table 125. Apotex Corp Introduction and Business Overview
Table 126. Apotex Corp Bisphosphonate Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Apotex Corp Bisphosphonate Drug Product
Table 128. Apotex Corp Recent Development
Table 129. Cobalt Pharmaceuticals Company Information
Table 130. Cobalt Pharmaceuticals Introduction and Business Overview
Table 131. Cobalt Pharmaceuticals Bisphosphonate Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Cobalt Pharmaceuticals Bisphosphonate Drug Product
Table 133. Cobalt Pharmaceuticals Recent Development
Table 134. Genentech Company Information
Table 135. Genentech Introduction and Business Overview
Table 136. Genentech Bisphosphonate Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Genentech Bisphosphonate Drug Product
Table 138. Genentech Recent Development
Table 139. Novartis Pharmaceuticals Company Information
Table 140. Novartis Pharmaceuticals Introduction and Business Overview
Table 141. Novartis Pharmaceuticals Bisphosphonate Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Novartis Pharmaceuticals Bisphosphonate Drug Product
Table 143. Novartis Pharmaceuticals Recent Development
Table 144. Sanofi-Aventis Company Information
Table 145. Sanofi-Aventis Introduction and Business Overview
Table 146. Sanofi-Aventis Bisphosphonate Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Sanofi-Aventis Bisphosphonate Drug Product
Table 148. Sanofi-Aventis Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Bisphosphonate Drug Market Trends
Table 152. Bisphosphonate Drug Market Drivers
Table 153. Bisphosphonate Drug Market Challenges
Table 154. Bisphosphonate Drug Market Restraints
Table 155. Bisphosphonate Drug Distributors List
Table 156. Bisphosphonate Drug Downstream Customers
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Bisphosphonate Drug Product Picture
Figure 2. Global Bisphosphonate Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Bisphosphonate Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Bisphosphonate Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Alendronate
Figure 6. Global Alendronate Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Risedronate
Figure 8. Global Risedronate Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Zoledronic Acid
Figure 10. Global Zoledronic Acid Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Other Bisphosphonate Drug
Figure 12. Global Other Bisphosphonate Drug Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Bisphosphonate Drug Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Bisphosphonate Drug Sales Market Share by Type in 2022 & 2029
Figure 15. North America Bisphosphonate Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Bisphosphonate Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Bisphosphonate Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Bisphosphonate Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Bisphosphonate Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Bisphosphonate Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Bisphosphonate Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Bisphosphonate Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Bisphosphonate Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Bisphosphonate Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Bisphosphonate Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Bisphosphonate Drug Revenue in 2022
Figure 27. Bisphosphonate Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Postmenopausal Osteoporosis
Figure 29. Global Postmenopausal Osteoporosis Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Men with Osteoporosis
Figure 31. Global Men with Osteoporosis Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Paget’s Disease
Figure 33. Global Paget’s Disease Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Bone Loss Caused by Cancer Treatment
Figure 35. Global Bone Loss Caused by Cancer Treatment Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Product Picture of Osteoporosis Imperfecta in Children
Figure 37. Global Osteoporosis Imperfecta in Children Sales YoY Growth (2018-2029) & (K Units)
Figure 38. Global Bisphosphonate Drug Sales by Application (2018-2029) & (US$ Million)
Figure 39. Global Bisphosphonate Drug Sales Market Share by Application in 2022 & 2029
Figure 40. North America Bisphosphonate Drug Sales Market Share in Volume by Application in 2022
Figure 41. North America Bisphosphonate Drug Sales Market Share in Value by Application in 2022
Figure 42. Europe Bisphosphonate Drug Sales Market Share in Volume by Application in 2022
Figure 43. Europe Bisphosphonate Drug Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Bisphosphonate Drug Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Bisphosphonate Drug Sales Market Share in Value by Application in 2022
Figure 46. Latin America Bisphosphonate Drug Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Bisphosphonate Drug Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Bisphosphonate Drug Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Bisphosphonate Drug Manufacturing Cost Structure
Figure 51. Bisphosphonate Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed